Richard LaRoche - National HealthCare Independent Director
| NHC Stock | USD 125.85 2.51 2.04% |
Director
Mr. Richard F. LaRoche, Jr. is an Independent Director of National HealthCare Corporationration He served NHC 27 years as Secretary and General Counsel and 14 years as Senior Vice President, retiring from these positions in May 2002. He has served as an NHC Board member since 2002. Mr. LaRoche also serves on the board of Cross Border Resources, Inc. and is chair of its Corporationrationrate Governance Committee and serves on its Audit Committee and Compensation Committee. He has a law degree from Vanderbilt University and an A.B. degree from Dartmouth College. Mr. LaRoche serves as a director of privately held Lodge Manufacturing Company and has previously served on the publicly held boards of National Health Investors, Inc., National Health Realty, Inc. and Trinsic, Inc. . Mr. LaRoches long career as former Secretary and General Counsel of the Company, during which time he was responsible for the Companys finance and development initiatives, provides the Board with invaluable experience in addressing the issues and challenges facing the Company. since 2002.
| Age | 74 |
| Tenure | 22 years |
| Address | 100 East Vine Street, Murfreesboro, TN, United States, 37130 |
| Phone | 615 890 2020 |
| Web | https://www.nhccare.com |
National HealthCare Management Efficiency
The company has Return on Asset of 0.0288 % which means that on every $100 spent on assets, it made $0.0288 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1324 %, implying that it generated $0.1324 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Capital Employed is projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.06, whereas Return On Equity is forecasted to decline to 0.07. At present, National HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.14, whereas Total Assets are forecasted to decline to about 772 M.Similar Executives
| Found 10 records | DIRECTOR Age | ||
| Frank Bumstead | Brookdale Senior Living | 78 | |
| Rita JohnsonMills | Brookdale Senior Living | 61 | |
| Mark Brookner | US Physicalrapy | 76 | |
| Marcus Bromley | Brookdale Senior Living | 70 | |
| Bernard Harris | US Physicalrapy | 64 | |
| Harry Chapman | US Physicalrapy | 76 | |
| Kathleen Gilmartin | US Physicalrapy | 69 | |
| Clayton Trier | US Physicalrapy | 69 | |
| Victoria Freed | Brookdale Senior Living | 63 | |
| Reginald Swanson | US Physicalrapy | 67 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0288 |
National HealthCare Leadership Team
Elected by the shareholders, the National HealthCare's board of directors comprises two types of representatives: National HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National HealthCare's management team and ensure that shareholders' interests are well served. National HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Adams, Non-Executive Chairman of the Board | ||
| Brian Kidd, Senior Vice President Principal Accounting Officer, Controller | ||
| Leroy McIntosh, Senior Vice President- Ancillary Services And Service Line Strategy. | ||
| Brian CPA, Senior CFO | ||
| W Adams, Director | ||
| Ernest Burgess, Independent Director | ||
| Stephen Flatt, Chief Executive Officer, Director | ||
| Richard LaRoche, Independent Director | ||
| Michael Ussery, President, Chief Operating Officer | ||
| Emil Hassan, Independent Director | ||
| Jeffrey Smith, Senior Vice President Treasurer | ||
| Anderson Sr, Senior Officer | ||
| Carl Adams, Founder | ||
| J Abernathy, Independent Director | ||
| Vicki Dodson, Senior Vice President - Patient Services | ||
| Josh McCreary, Senior Vice President General Counsel, Secretary | ||
| R Ussery, President, Chief Operating Officer | ||
| Timothy Shelly, Senior Operations | ||
| B Flatt, Senior Vice President, Chief Information Officer |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0288 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.93 B | ||||
| Shares Outstanding | 15.44 M | ||||
| Shares Owned By Insiders | 19.61 % | ||||
| Shares Owned By Institutions | 61.42 % | ||||
| Number Of Shares Shorted | 343.19 K | ||||
| Price To Earning | 22.85 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share 79.613 | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.